Newsroom

NEW YORK--(BUSINESS WIRE)--MSCI Inc. (“MSCI” or the “Company”) (NYSE: MSCI) will host a Q&A webinar to provide updates on MSCI’s Private Assets business, including strategic priorities, recent product innovation and AI-enabled capabilities. The webinar will include Luke Flemmer, Head of Private Assets and Jeremy Ulan, Head of Investor Relations and Treasurer, and will be moderated by Alex Kramm, Managing Director and Senior Equity Research Analyst at UBS. The virtual event will be available...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) (the “Company” or “Definium”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it intends to offer and sell, subject to market conditions, $500 million of its common shares and, to certain investors, pre-funded warrants to purchase common shares in an underwritten public offering. I...

MINNEAPOLIS--(BUSINESS WIRE)--Best Buy Co., Inc. (NYSE: BBY) today announced that Matt Bilunas will step down as Chief Financial Officer and depart the company at the end of July.Best Buy has engaged an external search firm for its next chief financial officer and expects to name a successor with previous CFO experience. Current CEO Corie Barry, who previously served as CFO, will provide financial oversight during the transition if needed."I am truly honored to have been part of this great compa...

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, concepteur de l'Edison® Histotripsy System et de plateformes thérapeutiques innovantes par histotripsie, a annoncé aujourd'hui la clôture d'un nouveau tour de table auquel ont participé Reed Jobs et Yosemite, ayant pour objectif de « rendre le cancer non mortel de notre vivant », ainsi que plusieurs nouveaux investisseurs stratégiques. Les autres modalités de ce financement n'ont pas été divulguées. Ce financement intervient alors que HistoSonics inter...

BOULDER, Colo.--(BUSINESS WIRE)--Gloo (Nasdaq: GLOO) and YouVersion today announced the Scripture in New Frontiers: A Virtual Summer Challenge, a global developer competition designed to explore how Scripture can be integrated into emerging digital experiences. Running July 6-31, 2026, on the innovation platform Kaggle, the challenge invites developers to experiment and build new applications using the YouVersion Platform and Gloo AI Studio.Register here for the challenge.Participants will compe...

PLANO, Texas--(BUSINESS WIRE)--The mall is officially your summer destination, and now every stop on your style journey just got more rewarding thanks to JCPenney and Aéropostale. For the first time ever, Aéropostale has launched a loyalty rewards program, and the two iconic mall staples are connecting their programs so every dollar you spend at either store – online, in the apps, or in store – earns you real money to spend at both. Plus, complete new challenges rolling out all summer and earn...

SAN DIEGO--(BUSINESS WIRE)--Driven by an extraordinary 54% surge in pharmaceutical exports to the United States—reaching €15.7 billion in 2025—Italy arrives at the BIO International Convention 2026 (San Diego, June 22-25) with an elite delegation of 20 companies, regional authorities, and research institutions. Organised within the Italian National Pavilion by the Italian Trade Agency (ITA) in collaboration with the Ministry of Foreign Affairs, International Cooperation (MAECI), the Ministry of...

BOSTON y BRISBANE, Australia--(BUSINESS WIRE)--AdvanCell, una empresa de radiofármacos en fase clínica especializada en el desarrollo de terapias alfa innovadoras dirigidas contra el cáncer, ha anunciado hoy que ha establecido su sede central internacional en Estados Unidos, en el área metropolitana de Boston. Por otro lado, alquilará instalaciones nuevas de 128 000 pies cuadrados, que serán el centro de fabricación insignia de la empresa en ese país y sustentarán su estrategia de crecimiento y...

BOSTON e BRISBANE, Australia--(BUSINESS WIRE)--AdvanCell, un’azienda farmaceutica di fase clinica specializzata in radiofarmaci e che si dedica allo sviluppo di terapie alfa mirate innovative per la cura dei tumori, ha annunciato oggi l’istituzione della propria sede centrale globale negli Stati Uniti nell’area metropolitana di Boston e la locazione di una nuova struttura di 128.000 piedi quadrati che diventerà il centro di produzione di punta dell’azienda negli Stati Uniti, a sostegno della su...

BOSTON & BRISBANE, Australië--(BUSINESS WIRE)--AdvanCell, een radiofarmaceutisch bedrijf in klinische fase dat innovatieve gerichte alfatherapieën ter behandeling van kanker ontwikkelt, kondigde vandaag de vestiging aan van zijn U.S. Global Headquarters in de regio van Groot-Boston en de lease van een nieuwe faciliteit van 128.000 vierkante voet groot, die het vlaggenschip productiecentrum in de V.S. zal worden, ter ondersteuning van groei op lange termijn en de commercialiseringsstrategie van...